“ Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency ” (2011) Clinics, 66(8), pp. 1361–1366. doi:10.1590/S1807-59322011000800009.